Clinical trial
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 · University of Washington, Other · Unknown status
Key facts
| NCT number | NCT00350194 |
|---|---|
| Title | The Effects of Omega-3 Fatty Acids on Metabolic Syndrome |
| Official title | Pilot Study: The Effects of Omega-3 Fatty Acids on Metabolic Syndrome and Vascular Structure in Metabolic Syndrome as Assessed by Carotid IMT |
| Lead sponsor | University of Washington, Other |
| Collaborators | Pfizer Industry National Institutes of Health (NIH) NIH Northwest Lipid Research Clinic |
| Status | Unknown status |
| Phase | Early Phase 1 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome X |
| Intervention type | Dietary Supplement |
| Interventions | Omega-3 fatty acids |
| Enrollment | 100 |
| Start date | Oct 1, 2006 |
| Primary completion | Oct 1, 2011 |
| Completion | Jun 1, 2012 |
| First posted | Jul 10, 2006 |
| Last update posted | Mar 2, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: